Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...

In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...

Spatial RNA medicine combines transcriptomics and RNA therapeutics, mapping gene expression in tissues to enhance precision ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

The field of genetic epidemiology has been revolutionized by recent advancements in next-generation sequencing technologies, as well as the development of ...

Cornell (NY, USA) researchers have found that a new DNA sequencing technology can be used to study how transposons move ...

The field of genomic medicine has experienced tremendous progress with the advent of next-generation sequencing (NGS), which ...

In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.

Nov 24 (Reuters) - NextDecade Corp (NEXT.O), opens new tab said on Monday it has started the U.S. regulatory pre-filing process to add a sixth liquefaction unit and an extra marine berth at its Rio ...

Cornell researchers have found that a new DNA sequencing technology can be used to study how transposons move within and bind ...